title: The Drug Enforcement Agency's position on "constructive transfer" under the Controlled Substances Act.
abstract: This article provides a summary of the Drug Enforcement Agency's current interpretation of the Controlled Substances Act as it relates to the "constructive transfer" of certain controlled substances from pharmacist to physician for office administration. The article discusses compliance with the Controlled Substances Act in this context and related legislative and legal activities of individual pharmacists and of the International Academy of Compounding Pharmacists and other groups.
authors.affiliation: Arnold & Porter, LLP, 555 Twelfth Street, NW, Washington, DC 2004-1206, USA. david.pore@aporter.com
authors.forename: R David
authors.initials: RD
authors.lastname: Pore
mesh_terms: D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D006077:Government Agencies; D061214:Patient Safety; D010595:Pharmacists; D014481:United States